Alerts will be sent to your verified email
Verify EmailWHBRADY
|
WH Brady
|
Signet Industries
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.06 % | 6.33 % | 28.02 % |
|
5yr average Equity Multiplier
|
1.63 | 3.64 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 1.34 | 1.43 |
|
5yr Avg Net Profit Margin
|
10.43 % | 1.3 % | 11.03 % |
|
Price to Book
|
1.71 | 0.62 | 0.62 |
|
P/E
|
8.48 | 8.72 | 15.71 |
|
5yr Avg Cash Conversion Cycle
|
71.04 Days | 125.15 Days | 154.28 Days |
|
Inventory Days
|
60.91 Days | 87.7 Days | 87.41 Days |
|
Days Receivable
|
78.47 Days | 119.88 Days | 103.86 Days |
|
Days Payable
|
69.16 Days | 86.07 Days | 63.18 Days |
|
5yr Average Interest Coverage Ratio
|
13.55 | 1.35 | 57.05 |
|
5yr Avg ROCE
|
15.82 % | 24.01 % | 36.52 % |
|
5yr Avg Operating Profit Margin
|
12.7 % | 7.16 % | 16.64 % |
|
5 yr average Debt to Equity
|
0.11 | 1.56 | 0.09 |
|
5yr CAGR Net Profit
|
36.84 % | 2.31 % | -5.76 % |
|
5yr Average Return on Assets
|
8.61 % | 1.74 % | 18.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.76 % | 73.3 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.73 % | -5.58 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
WH Brady
|
Signet Industries
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|